Lyrics (Intro) Yeah, It be R,E,H,D,O double G And I just want yall to know That this one is coming from the heart & soul So yall just understand me ya heard? Yo (Verse) Deep inside I hurt it makes me sad that when I open up my heart & soul People rip it out from inside my chest I do my best but God he made me to be Loving, caring, and understanding, compassionate to my fellow human And I can love you as if you were in my face or half way around the world Online friendships (Chorus) Im Depressed, God is this a test Im Depressed, God is this a test T,U,R,T,L,E J,B,O,N,E (Verse) God made me to be loving, caring, understanding and compassionate Even my enemies I cant hate them people say yo dont procrastinate Yo people (Chorus) Im Depressed, God is this a test Im Depressed, God is this a test (Verse) People take advantage of my kindness and they take it as a weakness Yo who really cares? How can I love so deep that it affects my life. J,B,O,N,E just need to know that youre doing okay Turtle I love you men thats from the heart youre my blood No matter what the people of the world may say its just Love (5 times)
From New York Times bestselling author Kresley Cole comes this scorching tale of a demon outcast poisoned with vampire blood and the
vulnerable young witch he vows to protect—even from himself.Learn more about this book, click on the link http://books.simonandschuster.com/Demon-from-the-Dark/Kresley-Cole/9781439123126 or visit simonandshuster.com . To learn more about the author, visit http://kresleycole.com/ Paranormal romance
http://www.darkmoonrisingmovie.com Real love and fate collide in this story about Amy, a small town girl, who falls in love with Dan a mysterious drifter who brings with him a family curse and the unimaginable horror that follows. Bender, who shares the curse with Dan, brings hell to town as Dan and Amy's love is put to the test. Sam the local Sheriff, Amy's father John and his friend and local rabble rouser Crazy Louis join forces with Thibodeaux, an excop from Bender's past who has witnessed his lust for blood firsthand and who's been hot on his heels for years.
Together, they head for the ultimate showdown with Bender and into the evil web of terror that he's twisted. Dark Moon Rising is an experience in love and horror that will keep the viewer guessing right up until the final frame.
Hunter, Carpathian and now Lycan, Fen is on a mission that puts him in danger if his secret if discovered. Tatijana of the Dragonseekers is of the earth and since being freed from captivity she will never be imprisoned by anyone or anything again. They are lifemates, they will share passion, blood and a secret that could get them both killed. Find out more at http://www.ChristineFeehan.com. Paranormal romance
Zev is an elite hunter, fierce and lethal. But when Branislava wakens him in a warrior’s cave where he was put for his own protection, Zev feels a new awakening in more ways than he could have ever imagined. Vampires and rogue Lycans are not all Zev and Branaslava will have to fight if they are to survive. A mysterious evil lurks nearby. One that not even the Carpathians can see coming. One that may cost them all dearly. Find out more at http://www.ChristineFeehan.com. Paranormal Romance
Significant advances toward cures for blood cancer patients, many of which were funded by The Leukemia & Lymphoma Society (LLS) over the past 65 years, are among the dramatic highlights featured in Ken Burns presents CANCER: THE EMPEROR OF ALL MALADIES, a film by Barak Goodman, to air on PBS stations nationwide from March 30-April 1. The documentary series is based on the Pulitzer Prize-winning book by Siddhartha Mukherjee, MD, The Emperor of All Maladies: A Biography of Cancer.
LLS has been a driving force behind treatment breakthroughs for patients with blood cancers, including leukemia, lymphoma and myeloma. As the world’s largest voluntary health agency dedicated to finding cures for blood cancer patients, LLS has invested more than $1billion in research to advance lifesaving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7409151-lls-cancer-research-pbs-series/
Blood is an essential component for life, but many people do not think about it until the need is critical. Each year 234 million major operations are performed worldwide, many involving blood transfusions or treatments resulting in a continuous need for donations.
That’s why Abbott (NYSE: ABT) and Real Madrid soccer star Cristiano Ronaldo are partnering to bring even more attention to this important cause. Regarded as one of the top soccer players in the world, Ronaldo will serve as the first global ambassador for the BE THE 1™ movement – developed to inspire young people around the world to regularly donate blood.
“We can all make a difference by donating blood. Each donation can benefit up to three people in emergency situations and for long-term medical treatments,” said Cristiano Ronaldo, forward for Real Madrid and Captain for Portugal National Football. “That’s why I am enthusiastic to be partnering with Abbott to bring awareness to the importance of blood donation and to encourage people around the world to become lifelong blood donors and help save lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7668251-abbott-cristiano-ronaldo-donate-blood/
Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced FDA 510(k) clearance has been granted for the CorPath 200 System to be used in percutaneous coronary interventions (PCI). The technology is now approved in the United States to assist interventional cardiologists in performing PCI, a procedure to restore blood flow to blocked arteries in patients with coronary artery disease (CAD).
“We are pleased to have received clearance from the FDA for the world’s first system designed for robotic-assisted PCI procedures,” said David M. Handler, President and CEO of Corindus Vascular Robotics. “This is an important milestone for interventional cardiology as we take the next step in transforming the way these procedures are performed in the future. The CorPath System offers hospitals the opportunity to bring robotic-assisted technology benefits to their coronary patients and their physicians.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/57343-corindus-vascular-robotics-wins-fda-510k-clearance-for-corpath-200-system
Ascensia Diabetes Care today announced the availability of the CONTOUR®NEXT ONE blood glucose monitoring system (BGMS) in the United Kingdom, one of the next steps in the evolution of self-monitoring of blood glucose. As part of the system, the CONTOUR®NEXT ONE meter and CONTOUR®DIABETES app seamlessly connect, which makes capturing blood glucose results effortless for people with diabetes. The system enables patterns and trends to be revealed that can help people understand their diabetes, and may help to improve diabetes management.
The system features an easy-to-use wireless-enabled smart meter that links to a smart mobile device via Bluetooth® connectivity. The CONTOUR®NEXT ONE meter gives immediate feedback and also seamlessly connects to the CONTOUR®DIABETES app, which collects, stores and analyses patient blood glucose results received from the meter. The app combines these results with other data recorded by the user, to provide detailed information about their condition that can help them understand how their everyday lives may impact their blood glucose readings, including alerts for critical high or critical low readings. Through the app, meter users can also share with their healthcare professional the reports of their blood glucose results and patterns, either in advance or on the day of their appointment, helping to create more informed discussions.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7954951-contour-next-one-bgms-ascensia/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
The CIGNA Health Awareness Tour Mobile Learning Lab is an experiential exhibit on 18 wheels that helps to raise awareness and understanding of traditional and non-traditional influencers of health.
Many health awareness efforts seek to increase individual understanding of the importance of key “numbers” or medical indicators of health, such as blood pressure and cholesterol levels. While these measures are important, the Mobile Learning Lab takes awareness to a new level, challenging guests to look at health more holistically.
To view Multimedia News Release, go to http://www.multivu.com/players/English/46644-CIGNA-Mobile-Learning-Lab/
